... Valcyte, ignoring a pre-grant opposition by two non-governmental organizations— the Indian Network for People Living with HIV/AIDS and the Tamil Nadu ...
... Valcyte, ignoring a pre-grant opposition by two non-governmental organizations— the Indian Network for People Living with HIV/AIDS and the Tamil Nadu ...
Mumbai: Adding fuel to an existing patent controversyinvolving Swiss drug maker F Hoffman-La Roche Ltd’s anti-infection drug Valcyte in India, the country’s ...
all 42 news articles
(India) Pvt. Ltd, agreed the Valcyte patent application in India made identical claims as in its 1994 US application, but insisted no rules had been ...
Such a claim, where the opponents of Roche’s Valcyte patent allege they were not given a hearing, is now being probed at the Chennai patent office. ...
VX: Quote, Profile, Research) to cut prices for its antiviral Valcyte in developing countries, saying it would help prevent unnecessary cases of blindness. ...
... patent to Swiss drug multinational F Hoffmann-La Roche Ltd for its anti-infection drug Valcyte, without hearing an opposition filed by a patient group. ...
... which the Swiss drug maker sells under the brand Valcyte, without hearing an opposition filed by a patient group as mandated under Indian patent rules. ...
Recently, the Chennai patent office had granted a patent for Roche’s Valcyte (Valganciclovir), indicated to treat the symptoms of cytomegalovirus (CMV) ...